45568 Federal Register / Vol. 71, No. 153 / Wednesday, August 9, 2006 / Notices 

1. VB Texas, Inc., Houston, Texas; to 

become a bank holding company by 

acquiring 100 percent of the voting 

shares of Community State Bank, 

Boling, Texas. 

Board of Governors of the Federal Reserve 

System, August 3, 2006. 

Jennifer J. Johnson, 

Secretary of the Board. 

[FR Doc. E6–12921 Filed 8–8–06; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL RESERVE SYSTEM 

Notice of Proposals to Engage in 

Permissible Nonbanking Activities or 

to Acquire Companies that are 

Engaged in Permissible Nonbanking 

Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y (12 

CFR Part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than August 23, 2006. 

A. Federal Reserve Bank of New 

York (Anne McEwen, Financial 

Specialist) 33 Liberty Street, New York, 

New York 10045-0001: 

1. Westpac Banking Corporation, 

Sydney, Australia; to engage de novo 

through its subsidiary, Hastings Funds 

Management (US), Inc., New York, New 

York, in providing investment and 

financial advice, pursuant to section 

225.28(b)(6) of Regulation Y. 

B. Federal Reserve Bank of San 

Francisco (Tracy Basinger, Director, 

Regional and Community Bank Group) 

101 Market Street, San Francisco, 

California 94105-1579: 

1. Belvedere Capital Fund II L.P. and 

Belvedere Capital Partners II LLC, both 

of San Francisco, California; to acquire 

Hometown Commercial Capital, LLC, 

Burlingame, California, and thereby 

engage in funding commercial real 

estate loans through established 

warehouse lines and subsequently 

securitizing pools through major Wall 

Street firms, pursuant to sections 

225.28(b)(1) and (b)(2)(ii) of Regulation 

Y. 

Board of Governors of the Federal Reserve 

System, August 3, 2006. 

Jennifer J. Johnson, 

Secretary of the Board. 

[FR Doc. E6–12922 Filed 8–8–06; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initiative To 

Integrate Clinical Laboratories into 

Public Health Testing, Funding 

Opportunity Number CDC–PA–HM06–

605 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting: 

Name: Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initiative to 

Integrate Clinical Laboratories into 

Public Health Testing, Funding 

Opportunity Number (FON) CDC–PA–

HM06–605. 

Times and Dates: 8:30 a.m.–4:30 p.m., 

August 3, 2006 (Closed). 

8:30 a.m.–4 p.m., August 4, 2006 

(Closed). 

Place: Centers for Disease Control and 

Prevention, Building 19, Conference 

Room 256, 1600 Clifton Road, Atlanta, 

GA 30333, Telephone 404.498.2329. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92–

463. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of applications received in 

response to FON CDC–PA–HM06–605, 

‘‘Initiative to Integrate Clinical 

Laboratories into Public Health 

Testing.’’

Due to programmatic matters, this 

Federal Register Notice is being 

published on less than 15 calendar days 

notice to the public (41 CFR 102–

3.150(b)). 

Contact Person for More Information: 

Jack Rogers, Ph.D., Program Analyst, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS 

E–21, Atlanta, GA 30333, Telephone 

404.498.2329. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: August 3, 2006. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 06–6802 Filed 8–8–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare and Medicaid 

Services 

[Document Identifier: CMS–10207] 

Emergency Clearance: Public 

Information Collection Requirements 

Submitted to the Office of Management 

and Budget (OMB) 

AGENCY: Center for Medicare and 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare and Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 153 / Wednesday, August 9, 2006 / Notices 45569 

We are, however, requesting an 

emergency review of the information 

collection referenced below. In 

compliance with the requirement of 

section 3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, we have 

submitted to the Office of Management 

and Budget (OMB) the following 

requirements for emergency review. We 

are requesting an emergency review 

because the collection of this 

information is needed before the 

expiration of the normal time limits 

under OMB’s regulations at 5 CFR part 

1320(a)(2)(ii). This is necessary to 

ensure compliance with an initiative of 

the Administration. We cannot 

reasonably comply with the normal 

clearance procedures because of an 

unanticipated event, as stated in 5 CFR 

1320.13(a)(2)(iii). 

The Centers for Medicare & Medicaid 

Services (CMS) is submitting an 

emergency information collection 

request for the approval of the 

information collection requirements 

associated with two new exceptions to 

section 1877 of the Social Security Act 

(the Act). The approval of this collection 

process is essential to protect the 

Medicare program and its beneficiaries 

against fraud and abuse. In addition, 

emergency approval is essential to 

permit members of the health care 

industry to immediately reap the 

benefits of this important regulation. 

Once the new exceptions are effective, 

entities that furnish certain designated 

health services to Medicare beneficiaries 

will be permitted to assist physicians 

with the implementation of electronic 

prescribing and electronic health 

records technology. The benefits of this 

technology include reducing medical 

errors, coordinating care, improving 

efficiency, and decreasing health care 

costs by eliminating unnecessary and/or 

duplicative diagnostic services. 

1. Type of Information Collection 

Request: New collection; Title of 

Information Collection: Physician SelfReferral Exceptions for Electronic 

Prescribing and Electronic Health 

Records; Use: Section 101 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA), directs the Secretary of the 

Department of Health and Human 

Services (‘‘HHS’’) to create an exception 

to the physician self-referral prohibition 

in section 1877 of the Social Security 

Act (the Act) for certain arrangements in 

which a physician receives 

compensation in the form of items or 

services (not including cash or cash 

equivalents) (‘‘nonmonetary 

remuneration’’) that is necessary and 

used solely to receive and transmit 

electronic prescription information. In 

addition, using our separate legal 

authority under section 1877(b)(4) of the 

Act, this rule creates a separate 

regulatory exception for certain 

arrangements involving the provision of 

nonmonetary remuneration in the form 

of electronic health records software or 

information technology and training 

services necessary and used 

predominantly to create, maintain, 

transmit, and receive electronic health 

records. 

The conditions for both exceptions 

require that arrangements for the items 

and services provided must be set forth 

in a written agreement, signed by the 

involved parties, specify the items or 

services being provided and the value of 

those items or services, and cover all of 

the electronic health records technology 

to be furnished by the entity. We have 

suggested that instead of one master 

contract that is updated with each new 

donation, the parties may choose to 

create a specific new contract and then 

reference other agreements or crossreference a master list. 

The requirements associated with 

these exceptions are limited to 

donations made to physicians by 

providers, members of integrated 

delivery systems, Federally Qualified 

Health Centers, or rural health clinics 

(for purposes of this Collection of 

Information Requirement, ‘‘Providers’’); 

by group practices to their physician 

members, and by Prescription Drug Plan 

(PDPs) sponsors and Medicare 

Advantage (MA) organizations to 

prescribing physicians. The paperwork 

burden is the creation of the written 

contracts. The burden associated with 

the written agreement requirement is 

the time and effort necessary for 

documentation of the agreement 

between the parties, including 

signatures of the parties. Form Number: 

CMS–10207 (OMB#: 0938–NEW); 

Frequency: Recordkeeping and 

Reporting—On occasion; Affected 

Public: Business or other for-profit and 

Not-for-profit institutions; Number of 

Respondents: 87,230; Total Annual 

Responses: 87,080; Total Annual Hours: 

50,731. 

CMS is requesting OMB review and 

approval of this collection by September 

22, 2006, with a 180-day approval 

period. Written comments and 

recommendations will be considered 

from the public if received by the 

individuals designated below by 

September 18, 2006. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

regulations/pra or E-mail your request, 

including your address, phone number, 

OMB number, and CMS document 

identifier, to Paperwork@cms.hhs.gov, 

or call the Reports Clearance Office on 

(410) 786–1326. 

Interested persons are invited to send 

comments regarding the burden or any 

other aspect of these collections of 

information requirements. However, as 

noted above, comments on these 

information collection and 

recordkeeping requirements must be 

mailed and/or faxed to the designees 

referenced below by September 18, 

2006: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development—

B, Attn: William N. Parham, III, Room 

C4–26–05, 7500 Security Boulevard, 

Baltimore, MD 21244–1850 and, OMB 

Human Resources and Housing Branch, 

Attention: Carolyn Lovett, New 

Executive Office Building, Room 10235, 

Washington, DC 20503, Fax Number: 

(202) 395–6974. 

Dated: August 2, 2006. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 06–6773 Filed 8–3–06; 4:04 pm] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2006N–0219] 

Antiviral Drugs Advisory Committee; 

Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Antiviral Drugs 

Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on October 19, 2006, from 8 a.m. 

to 4 p.m. and on October 20, 2006, from 

8 a.m. to 4 p.m. 

Addresses: Electronic comments 

should be submitted to http:// 

www.fda.gov/dockets/ecomments. 

Select ‘‘2006N–0219—Clinical Trial 

Design Issues in the Development of 

Products for Treatment of Chronic 

Hepatitis C’’ and follow the prompts to 


jlentini on PROD1PC65 with NOTICES